These are the questions I'd ask too. Here are my honest answers.
Good. That's the right instinct. Most things that sound too good to be true are.
So let me tell you what changed my mind. I didn't start by believing in a product. I started by asking a question: how important is redox signaling to the human body?
Here's what I found:
When that same AI was asked what health challenges a perfect redox modulator might affect, its answer was simple: virtually all of them — because the medical literature identifies oxidative stress as a root cause or major accelerant of nearly every chronic condition we face.
None of that has anything to do with ASEA. That's the category of science. The question of whether one company has actually figured out how to stabilize these molecules outside the body — that's a separate question, and a fair one.
Here's one more thing to consider: the company behind this technology does a few hundred million in annual revenue. Meanwhile, the AI estimated the patent value of a true redox homeostatic modulator at hundreds of billions. That gap doesn't mean it doesn't work. It means the world hasn't caught up yet — which is exactly what the PubMed growth curve, the handwashing analogy, and James Watson's pivot all suggest.
Here's what I'd suggest: don't take my word for it. Look up "redox signaling" on PubMed.gov yourself. Read about Dr. Gary Samuelson, the atomic medical physicist who stabilized the molecules. Watch the Genesis video. Talk to me, and I'll share what I've seen — not as a salesman, but as someone who was exactly as skeptical as you are right now.
The difference between "too good to be true" and "too important to ignore" is evidence. I think the evidence is there. But I'd rather you decide that for yourself.
I get why people say that. The ingredients list shows salt and water. But that's what goes in — not what comes out. It's like saying the ingredients of a diamond are "carbon" — technically true, completely misleading.
What matters is what happens to those ingredients during a patented electrochemical process — roughly 18 hours per batch — that reorganizes them into redox signaling molecules — the same type of molecules your cells already produce. The process is patented because no one else has figured out how to stabilize these molecules outside the body.
If it were just salt water, it wouldn't have those patents, it wouldn't show results in published studies, and I wouldn't be sharing it with people I care about.
Dr. Ahvie Herskowitz, a board-certified physician in San Francisco who has used ASEA with thousands of patients over more than a decade, put it this way: “It's a miracle that something like this exists.”
Because the science is ahead of public awareness. Go to PubMed.gov — the U.S. National Library of Medicine's research database — and search "redox signaling." You'll find over 4,000 published papers, and the growth curve is accelerating. In the first half of 2026 alone, 259 new papers were published — a pace that would nearly double last year's total.
The research is there. It just hasn't made the leap from the lab to the doctor's office yet — and that's normal. Think about how long it took for the microbiome to go from obscure science to something everyone talks about. Redox signaling is on that same trajectory, just earlier on the curve.
The fact that you haven't heard of it isn't a red flag. It's the whole point.
I understand the skepticism — the industry has earned it. But here's a distinction that matters: ASEA isn't a network marketing company that came up with a product. It's an R&D biotech company that uses network marketing as its distribution model.
The science came first. Medical Discoveries, Inc. spent years and millions developing what they named MDI-P. Verdis Norton purchased the research and patents and within months, discovered not only that MDI-P was actually unstabilized redox signaling molecules, but also, under the direction of Dr. Gary Samuelson, stabilized the molecules.
Their exit strategy was not to create a network marketing company — it was to sell it to big pharma so they would be the distribution vehicle. Barr Pharmaceuticals flew a team of scientists to Salt Lake City, studied the work, and said, “We want to buy this.”
But there was a condition. The pharmaceutical company would own the product entirely. Everyone who was already using it would have to stop. Norton told them he had people who believed this product had saved their lives — he couldn't pull it away from them.
The pharmaceutical executive looked at him and said, “Verdis, people die every day. Pull them off it. We own it now.”
Norton walked away. He later said his grandchildren's grandchildren would never have had to work another day in their lives from what that deal was worth. He walked away anyway.
The problem remained: the label says salt and water. No retail store is going to put that on a shelf and expect it to sell itself. It requires education. It requires someone explaining what it actually is and why it matters. Word of mouth wasn't just the best distribution model — it was the only one that made sense for a product this misunderstood.
So yes, the distribution is network marketing. But the company is biotech. The product came from science, not from a business model looking for something to sell. That's a meaningful difference.
If the business side interests you, great — we can talk about that. If it doesn't, that's fine too. The product works the same either way.
ASEA's technology originated with a company called Medical Discoveries, Inc. — a Utah-based bio-pharmaceutical company incorporated in 1991. MDI was publicly traded, filed with the SEC, and spent over a decade and millions of dollars developing a product called MDI-P: an anti-infective solution made from electrolyzed saline containing stabilized reactive molecules.
This wasn't garage science. MDI-P was tested at some of the most respected research institutions in the country — Dana-Farber Cancer Institute (a Harvard affiliate), Albany Medical College, Baylor College of Medicine, Indiana University, UCLA, and the University of Washington. The company filed an Investigatory New Drug application with the FDA for Cystic Fibrosis and HIV. They held eight U.S. patents, two Japanese patents, and one Mexican patent.
At Dana-Farber, MDI-P destroyed over 90% of HIV in cell cultures — with no cell toxicity. At Albany Medical College, it cleared Legionella and Candida within 60 seconds. In chronic toxicity studies, six months of weekly injections in mice showed zero toxic effects. This is all in the public record — you can look up the SEC filing yourself.
When MDI eventually ran out of funding, Verdis Norton — a retired Kraft Foods executive who had been consulting for the company — recognized what they had. He assembled an investment team, purchased the research and patents, and brought in atomic medical physicist Dr. Gary Samuelson to take the science further. Samuelson's breakthrough was stabilizing these reactive molecules in a bio-identical form that could last 18–24 months in a bottle. That became ASEA.
If you want the full origin story in the founders' own words, search for the ASEA Genesis video — it's worth the watch.
This is probably the most important question on this page, so I want to give it a real answer.
Dr. Ahvie Herskowitz — a cardiologist and immunologist who trained at Albert Einstein College of Medicine, Johns Hopkins, and UCSF, with over 115 peer-reviewed publications — puts it bluntly: developing a drug through the FDA for a single indication costs somewhere between $250 million and a billion dollars. And that approval would cover one condition. The FDA's framework is designed for one drug, one disease. If you took something like this to the FDA, they wouldn't know what to do with it — because it's too foundational to fit any single division.
As Dr. Herskowitz explains: “The FDA had no ability to understand mitochondrial modulation. They said, 'How could it be that one thing could impact every animal model you ever tested?' That's the criticism. But the reason it works is because it's a fundamental process.”
That said, the science isn't absent — it's just not packaged the way people expect. There are pre-clinical studies from Dana-Farber Cancer Institute, Albany Medical College, Baylor, and the University of Washington. There's a double-blind metabolomics study from Appalachian State University that found ASEA shifted 43 metabolites in just seven days — a result that stunned the research team. There's a gene expression study showing significant activation of signaling pathway genes. And there are over 50,000 peer-reviewed papers on redox signaling biology in the PubMed database.
Dr. Herskowitz also offers some perspective: “Handwashing took 40 years in the 1800s. And that's probably around the right amount of time. ASEA is what, 15, 20 years old? You have to count to 40 years before anyone would actually do it.”
He didn't need a billion-dollar trial to convince himself. He put approximately 100 of his own patients on it — ranging from world-class athletes to Stage 4 cancer patients — and watched the results. His conclusion: “Everything gets better.”
It varies. Some people notice changes in days. For me, it was more like 2–3 weeks of subtle shifts — better sleep, steadier energy, faster recovery. For others, it takes a month or two.
The honest answer is: this isn't caffeine. It's not designed to give you a jolt. It's designed to support your body's own processes, and those processes take time. The people who tend to notice the most are the ones who pay attention to the quiet changes rather than waiting for something dramatic.
Dr. Ray Dixon — a chiropractor, osteopath, and naturopath with 38 years of clinical practice — puts it simply: “Your magic is between two cups a day and that bottle a day.”
A bottle is 32 ounces. A cup is about 2 ounces. Here's the general range he recommends:
He also stresses giving it time — a minimum of 3–4 months to really notice changes. The body rebuilds gradually. Chronic issues may retrace over the course of a year or more.
As he puts it: “It's not about working or not working. If you've got something universally profound, of course it's working. It's whether you're working — staying consistent, giving it enough time, and paying attention to the quiet shifts.”
The honest answer? It depends on how you buy it.
A case of four bottles on Amazon runs about $207. The same case through ASEA directly, as a Brand Partner on subscription, is $140 — that's a $67 difference every month. Brand Partner enrollment is $40 one-time, so the savings pay for themselves in the first order. There's also a 10% discount on your first order with the promo code redoxsolution.
For context, $140 a month works out to about $4.60 a day — roughly what many people spend on coffee. I understand that's still real money, and I'm not going to tell you it's cheap.
What I will say is this: the production process takes roughly 18 hours per batch using a patented technology no one else has. This isn't a powder mixed in a warehouse. And unlike most supplements that give your body something it doesn't naturally use, this gives your body back something it already makes — just not enough of anymore.
The question I'd ask isn't “is it expensive?” It's “what's it worth to feel like your body is working the way it's supposed to?”
You absolutely should. Nothing replaces nutrition, movement, sleep, and stress management. This doesn't compete with any of that — it supports it.
Think of it this way: eating well gives your body the raw materials. Exercise builds strength and endurance. But neither of those can increase the production of redox signaling molecules your body has been losing since puberty. That decline happens regardless of how healthy your lifestyle is.
This isn't instead of a healthy life. It's the piece most healthy people are missing.
I'm glad you feel fine. Genuinely. But here's something worth sitting with:
"Feeling fine" and "functioning optimally at the cellular level" are not the same thing. Your body is doing extraordinary work right now that you'll never feel — identifying and eliminating cellular threats, repairing DNA damage, clearing out cells that aren't functioning correctly. It does this silently, around the clock, without sending you a notification.
The question isn't whether that system works. It's whether it has the same resources to work as well as it did 20 years ago.
As Dr. Ray Dixon puts it after 38 years of clinical practice: everyone past puberty is deficient in redox signaling molecules. Not "might be." Is. It's simple math — roughly 1% fewer per year, no exceptions, regardless of how healthy your lifestyle is. A 50-year-old has significantly fewer of these molecules than they did at 20, no matter how well they eat or how often they exercise.
Most people don't think about cellular maintenance until something forces them to. This is a chance to think about it before that happens.
The FDA doesn't approve supplements — that's not how the system works. What the FDA does is regulate manufacturing standards, and ASEA is produced in an FDA-registered, NSF-certified facility that meets pharmaceutical-grade standards.
Third-party verification of the redox signaling molecules in ASEA was originally performed by BioAgilytix, a leading biosafety lab. That verification has since been transferred to BQC Redox Technologies Laboratories (Bioquochem) — a Spanish biotechnology company that specializes in measuring redox parameters and oxidative stress biomarkers. They are not an ASEA laboratory, which is actually a positive thing if you're looking for independent validation.
It's not a drug, it's not making drug claims, and it's manufactured to a standard that exceeds most of what's on supplement shelves.
It's different for each person. Some people barely notice it, others find it unusual at first. The interesting thing is that over time, it starts to taste like water as your body becomes more balanced.
But here's the thing: if you're choosing a health product based on taste, you're optimizing for the wrong thing. This isn't a smoothie. It's cellular support. The taste is a function of what the molecules are, not a failure of flavoring.
Most supplements add something to your body — a vitamin, a mineral, an herb. Your body then has to figure out what to do with it.
Redox signaling molecules are different. Your body already makes them. It already knows exactly what to do with them. The problem isn't that your body doesn't recognize them — it's that your body doesn't make enough of them anymore.
This is the difference between giving someone a tool they've never used and giving a master craftsman back the tool they've been missing. The body doesn't need instructions. It needs supply.
This is one of the best questions you can ask, because it gets to the heart of what makes this technology different from everything else on the market.
Glutathione is real. It IS your body's master antioxidant. Your liver makes it. Your immune system runs on it. Your mitochondria depend on it. Production does decline with age. All of that is true.
So the obvious solution is to take a glutathione supplement, right? That's what companies selling liposomal glutathione are betting on. But there's a fundamental problem:
Exogenous glutathione — glutathione made outside your body — doesn't know when to stop.
Think of it this way: your body has its own built-in security team. They know the neighborhood. They know when to show up, how hard to respond, and when to stand down. That's endogenous glutathione — produced internally, regulated by your body's own intelligence.
Taking a glutathione supplement is like hiring outside security guards who don't know the neighborhood. They show up ready to work, but they don't know which threats are real and which ones already passed. So they just keep patrolling — whether there's a problem or not. That can actually cause its own kind of imbalance.
ASEA works differently. Instead of dumping outside glutathione into your system, redox signaling molecules trigger your body to produce its own. The body decides how much, when, and where. Scientists call this automodulation — the body self-regulates production based on actual need. That's only possible when you restore the signaling, not when you bypass it.
A recent 16-week clinical study confirmed this: participants supplementing with redox signaling molecules showed significant improvements in their body's own antioxidant and resilience markers — not because something was added from outside, but because the body's internal systems were reactivated.
The distinction matters: one approach gives your body a tool it didn't ask for. The other restores your body's ability to use the tools it already has.
Dr. Lee Ostler, a practicing dentist and cellular health researcher, uses an analogy that makes this click:
Think of a thermostat on your wall.
It senses the conditions in the room. When something is off — too hot, too cold — it activates a response. The heating or cooling system kicks in, corrects the problem, and when everything is back in balance, the thermostat turns the system off.
Your cells work the same way.
Redox signaling molecules are your body's thermostat. They sense when something is wrong at the cellular level. They activate the gene pathways that respond to the problem — turning on your body's natural defense, repair, and antioxidant systems. And when the problem is corrected and balance is restored, they turn those systems off.
That last part is crucial. It's not just about turning things on — it's about knowing when to turn them off. Chronic issues often arise not because the body can't respond, but because it can't stop responding. A stuck thermostat that never shuts off is just as problematic as one that never turns on.
This is why redox signaling isn't just another supplement doing one thing. It's the regulatory mechanism behind everything else. Dr. Ostler calls it “one to many” — support the cell, and many things benefit downstream. Medicine typically works one-to-one: one drug for one disease. Cellular health works one-to-many.
It's impossible for it not to work. Your cells need redox signaling molecules the way they need oxygen — it's not optional biology. What is possible is that you don't feel anything, and that's actually common.
Dr. Ahvie Herskowitz — an integrative medicine physician in San Francisco — explains it this way: “The overwhelming majority of us would not feel a thing if we took it every day — because it's so methodical, so fundamental, so slow to recover the systems that have been not working at full speed.”
The improvements are often so gradual that they become invisible — a little less stiffness, slightly better sleep, sharper thinking. You don't notice what quietly got better. But here's the pattern he sees over and over: people stop after 90 days thinking nothing happened. Then the subtle things that improved start coming back. And they call asking to restart.
As he puts it: “They go off and they say, 'I want it back, please,' because I now notice the subtleties.”
Give it at least 90 days. Pay attention to the quiet shifts, not just the dramatic ones. And if you want a real test — stop for a month and see what you notice.
Still have questions? I'd rather have a real conversation than send you to another page.
Email Fritz